Hostname: page-component-77c89778f8-cnmwb Total loading time: 0 Render date: 2024-07-19T06:01:28.887Z Has data issue: false hasContentIssue false
  • English
  • Français

Olanzapine in haloperidol treatment failure

Published online by Cambridge University Press:  16 April 2020

K. Mraz ,
L. Alexandrescu ,
B. Klar ,
D. Uta ,
P. Kratky  and
M. Dossenbach
K. Mraz
Affiliation:
Eli Lilly, Vienna, Austria
L. Alexandrescu
Affiliation:
Policlinica Universitara Iitan, Bucharest
B. Klar
Affiliation:
Eli Lilly, Romania
D. Uta
Affiliation:
Eli Lilly, Vienna, Austria
P. Kratky
Affiliation:
Eli Lilly, Vienna, Austria
M. Dossenbach
Affiliation:
Eli Lilly, Vienna, Austria

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 13 , Issue S4: Standards of psychiatry - 9th Congress of Association of European Psychiatrists , 1998 , pp. 255s
Copyright
Copyright © European Psychiatric Association 1998
Submit a response

Comments

No Comments have been published for this article.